REQUEST A DEMO
Total
USD $0.00
Search more companies

GUP Rk Krym-Farmaciya (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: GUP Rk Krym-Farmaciya Profile Updated: September 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

GUP Rk Krym-Farmaciya is a company based in Russia, with its head office in Simferopol. The company operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on September 08, 2014. In its most recent financial highlights, the company reported a net sales revenue increase of 21.73% in 2022. Over the same period, its total assets decreased by 14.1%. In 2022, GUP Rk Krym-Farmaciya’s net profit margin increased by 0.66%.

Headquarters
Rechnaya, 12
Simferopol; Crimea Republic; Postal Code: 295000

Contact Details: Purchase the GUP Rk Krym-Farmaciya report to view the information.

Website: http://rkfarm.ru

Basic Information
Outstanding Shares:
Purchase the GUP Rk Krym-Farmaciya report to view the information.
Registered Capital:
Purchase the GUP Rk Krym-Farmaciya report to view the information.
Incorporation Date:
September 08, 2014
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after GUP Rk Krym-Farmaciya report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
21.73%
Total operating revenue
21.73%
Operating profit (EBIT)
56.42%
Net Profit (Loss) for the Period
240.22%
Total assets
-14.1%
Total equity
15.21%
Operating Profit Margin (ROS)
1.6%
Net Profit Margin
0.66%
Return on Equity (ROE)
6.83%
Quick Ratio
0.01%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?